BRIDGEWATER, N.J., April 28, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile ...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals announced today it has received U.S. Food and Drug Administration (FDA) approval for its patent-pending New Drug Application (NDA) Emerphed, ...

The FDA approved the New Drug Application (NDA) for Emerphed (Nexus Pharmaceuticals), a premixed, ready-to-use formulation of ephedrine sulfate. The Food and Drug Administration has approved the New ...

DUBLIN, March 28, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its Par Sterile Products business has begun shipping premixed Ephedrine Sulfate Injection in a ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DBL Ephedrine Sulfate Injection contains the active ingredient ...

What is ephedrine used for? Ephedrine is commonly used to relieve mild symptoms of asthma, such as wheezing, chest tightness, and shortness of breath. Ephedrine may also be used for other conditions ...

BRIDGEWATER, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nevakar Inc., a biopharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced today it received approval ...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals announced today that it has launched its patent-pending New Drug Application (NDA) Emerphed, the first and only premixed ephedrine in a ready ...